ACT Capital Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $73K | Hold |
725
| – | – | 0.1% | 52 |
|
|
2022
Q2 | $88K | Hold |
725
| – | – | 0.12% | 52 |
|
|
2022
Q1 | $150K | Hold |
725
| – | – | 0.16% | 57 |
|
|
2021
Q4 | $144K | Hold |
725
| – | – | 0.1% | 76 |
|
|
2021
Q3 | $201K | Hold |
725
| – | – | 0.1% | 82 |
|
|
2021
Q2 | $259K | Buy |
+725
| New | +$259K | 0.13% | 81 |
|